Treatment for rejuvenating skin around the eyes using a 1927 nm diode laser
An Open-Label, Single Center Clinical Study to Evaluate the Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment
This study is testing a new laser treatment to see if it can improve the skin around the eyes for people looking to rejuvenate that area.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 30 Years to 65 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05811026 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the efficacy and safety of a 1927 nm diode laser for rejuvenating the skin around the eyes. Participants will be randomized into two groups, receiving treatments at either a 2-week or 4-week interval using the Solta CLEAR+BRILLIANT Laser System. The study aims to assess the therapeutic effects of this laser treatment on periorbital skin, focusing on treatment design and outcomes. It is an open-label, single-center trial conducted at the National Taiwan University Hospital.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 30 to 65 years with no significant skin lesions or inflammation.
Not a fit: Patients with chronic skin diseases, recent facial treatments, or serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive option for improving the appearance of skin around the eyes.
How similar studies have performed: Other studies using laser treatments for skin rejuvenation have shown promising results, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged between 30 and 65 years old; 2. no significant skin lesions or inflammation on the facial skin; 3. willing and able to comply with study requirements, instructions, and restrictions; 4. signed informed consent form. Exclusion Criteria: 1. underwent facial active treatment, such as using laser, intense pulsed light, radiofrequency skin tightening, ultrasound skin tightening, botulinum toxin, or dermal fillers injection, within the previous six months; 2. have chronic skin diseases such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo, rosacea, or keloid; 3. pregnant or breastfeeding; 4. suffered from acute illnesses or infections requiring treatment within 14 days before entering the study; 5. have had serious illnesses (such as heart disease, lung disease, brain disease, or liver disease) within the previous three months; 6. allergic to Lidocaine or Prilocaine used in topical anesthetic cream or suffer from methemoglobinemia; 7. used any skin medication on the face within 30 days before the trial, deemed by the principal investigator to affect the study results; 8. deemed unsuitable for the study by the principal investigator.
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Chang-Ming Huang, MD
- Email: daniel510791@gmail.com
- Phone: +886-987793689
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.